May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension
the MMM Investigators
Oxford University Press
MetadataShow full item record
Aims Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. Methods and results Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. Conclusion May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.
European Heart Journal;
Beaney, T., Burrell, L.M., Castillo, R.R., Charchar, F.J., Cro, S., Damasceno, A., Kruger, R., Nilsson, P.M., Prabhakaran, D., Ramirez, A.J., Schlaich, M.P., et al (2019) 'May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension', European Heart Journal. https://doi.org/10.1093/eurheartj/ehz300
Article published in European Heart Journal available open access at https://doi.org/10.1093/eurheartj/ehz300
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Showing items related by title, author, subject and abstract.
May Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland—Europe McDonnell, Barry; Keitley, James; Beaney, Thomas; Tay, Tricia; Brady, Adrian J.B.; Padmanabhan, Sandosh; Cockcroft, John; Dolan, Eamon; Heagerty, Anthony; Greenstein, Adam; Tomaszewski, Maciej; Schtte, Alta E.; Poulter, Neil R.; Cappuccio, Francesco P. (Oxford University Press, 2019-04-24)Elevated blood pressure (BP), or hypertension, is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and acting ...
Beaney, T.; Schutte, A.E.; Tomaszewski, M.; Ariti, C.; Burrell, L.M.; Castillo, R.R.; Charchar, F.J.; Damasceno, A.; Kruger, R.; Lackland, D.T.; Nilsson, P.M.; MMM Investigators; McDonnell, Barry (Elsevier, 2018-05-16)Background Increased blood pressure is the biggest contributor to the global burden of disease and mortality. Data suggest that less than half of the population with hypertension is aware of it. May Measurement Month was ...
Prevalence of metabolic risk factors and associated 10‐year prediction of cardiovascular disease and diabetes in female employees Gray, B.; Bracken, R.; Turner, D.; Morgan, K.; Mellalieu, Stephen D.; Thomas, M.; Williams, Sally P.; Williams, M.; Rice, S.; Stephens, J.W. (Wiley, 2014-09-08)Cardiovascular disease (CVD) and type 2 diabetes (T2DM) remain two of the greatest health challenges in the United Kingdom. Guidelines currently advocate screening individuals to identify those at ‘high risk’ (10‐year risk ...